Genes Clinical Trial - Scripps Genomics Health Initiative

Status Active, not recruiting

Clinical Trial Summary

The specific aims for this project are to enroll up to 10,000 subjects who will have their genomes surveyed using the Navigenics™ Health Compass technology. The Navigenics Health Compass helps you understand what your genetic variants have to say about the future of your health, and gives you action steps to take control of your health today. In addition, the investigators will assess how the Navigenics Health Compass, results affect lifestyle decisions. The phenotyping information that can be analyzed with the resulting Navigenics genotype information will assist in identifying genetic variations associated with other traits and diseases. The uses of molecular markers such as cholesterol and glucose levels to assess disease risk are well established in clinical medicine today. Although these tools are useful in screening for subclinical disease, their predictive value is limited. Until recently, these molecular markers were the best risk assessment and screening tools in existence. Since the completion of the Human Genome Project, the era of personalized medicine, which exploits knowledge of the genes an individual carries that may predispose him/her to disease, has come to the forefront of research. The Navigenics Health Compass technology assesses risk for about over 20 common diseases and provides subjects with more accurate assessments of their individual predictive risk for developing these conditions than traditional biomarkers such as cholesterol and glucose levels. This may positively influence changes in lifestyle, as well as decisions to seek further medical evaluation associated with preventive strategies.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Genes

Clinical Trial Details

NCT number	NCT00808587
Study type	Observational
Source	Scripps Translational Science Institute
Contact
Status	Active, not recruiting
Phase
Start date	October 2008
Completion date	March 2029

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04034667` - Study of CT and MR in the Lung Cancer
Completed	`NCT02642640` - Interaction of Melatonin and MTNR1B Genotype on Glucose Control - Study 1	N/A
Recruiting	`NCT06125314` - HER2 TREAT Study: Retrospective Study to Estimate the Prevalence of HER2-low in Unresectable and/or Metastatic Breast Cancer Patients Who Progress on Anti-Cancer Therapy Identified as HER2-Negative From Patient Medical Records in The Gulf Cooperation Council
Recruiting	`NCT01200680` - Genetic Clues to Chordoma Etiology: A Protocol to Identify Sporadic Chordoma Patients for Studies of Cancer-Susceptibility Genes
Completed	`NCT03464084` - Interaction of Melatonin With MTNR1B Genotype on Glucose Control - Study 2	N/A